GZD-856

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameGZD-856
Drug Alias NameGZD-856
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionABL proto-oncogene 1 inhibitors
TargetsABL proto-oncogene 1
Therapy Area/IndicationsLeukemia, Myeloid, Chronic-Phase
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Chronic-Phase
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A